UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

“If they tell me to get it, I'll get it. If they don't….”: Immunization decision-making processes of immigrant mothers

Canadian journal of public health, 2015-05, Vol.106 (4), p.e230-e235

2015

Volltextzugriff (PDF)

The global landscape of stem cell clinical trials

Regenerative medicine, 2014-01, Vol.9 (1), p.27-39

2014

Volltextzugriff (PDF)

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications

Stem cell reports, 2017-05, Vol.8 (5), p.1190-1201

2017

Volltextzugriff (PDF)

Application of protection motivation theory to clinical trial enrolment for pediatric chronic conditions

BMC pediatrics, 2020-03, Vol.20 (1), p.123-123, Article 123

2020

Volltextzugriff (PDF)

Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation

PLoS biology, 2015-02, Vol.13 (2), p.e1002060-e1002060

2015

Volltextzugriff (PDF)

Let’s do better: public representations of COVID-19 science

Facets (Ottawa), 2021-03, Vol.6 (1), p.403-423

2021

Volltextzugriff (PDF)

Role and reality: technology transfer at Canadian universities

Trends in biotechnology (Regular ed.), 2010-09, Vol.28 (9), p.447-451

2010

Volltextzugriff (PDF)

Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis

PloS one, 2023-11, Vol.18 (11), p.e0294608-e0294608

2023

Volltextzugriff (PDF)

Asynchronous online focus groups for research with people living with amyotrophic lateral sclerosis and family caregivers: usefulness, acceptability and lessons learned

BMC medical research methodology, 2023-10, Vol.23 (1), p.1-222, Article 222

2023

Volltextzugriff (PDF)

Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis

BMC neurology, 2022-04, Vol.22 (1), p.140-140, Article 140

2022

Volltextzugriff (PDF)

Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness

Frontiers in medicine, 2022-02, Vol.8, p.818647-818647

2022

Volltextzugriff (PDF)

Governance of a global genetic resource commons for non-commercial research: a case-study of the DNA barcode commons

International journal of the commons, 2019-01, Vol.13 (1), p.205-243

2019

Volltextzugriff (PDF)

Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers

Canadian Medical Association journal, 2004-04, Vol.170 (9), p.1399

2004

Volltextzugriff (PDF)

Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

BMC public health, 2020-01, Vol.20 (1), p.89-89, Article 89

2020

Volltextzugriff (PDF)

Is belief larger than fact: expectations, optimism and reality for translational stem cell research

BMC medicine, 2012-11, Vol.10 (1), p.133-133, Article 133

2012

Volltextzugriff (PDF)

Patent landscaping for life sciences innovation: toward consistent and transparent practices

Nature biotechnology, 2013-03, Vol.31 (3), p.202-206

2013

Volltextzugriff (PDF)

When pictures waste a thousand words: analysis of the 2009 H1N1 pandemic on television news

PloS one, 2013-05, Vol.8 (5), p.e64070-e64070

2013

Volltextzugriff (PDF)

"I have such a hard time hitting myself, I thought it'd be easier": perspectives of hospitalized patients on injecting drugs into vascular access devices

Harm reduction journal, 2022-05, Vol.19 (1), p.54-54, Article 54

2022

Volltextzugriff (PDF)

Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence

Frontiers in neurology, 2021-08, Vol.12, p.683197-683197

2021

Volltextzugriff (PDF)

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate

PLoS biology, 2013-11, Vol.11 (11), p.e1001699-e1001699

2013

Volltextzugriff (PDF)

The Impact of Heterogeneity in a Global Knowledge Commons: Implications for Governance of the DNA Barcode Commons

International journal of the commons, 2019-01, Vol.13 (2), p.909-930

2019

Volltextzugriff (PDF)

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

NPJ precision oncology, 2022-10, Vol.6 (1), p.76-76, Article 76

2022

Volltextzugriff (PDF)

Provenance and risk in transfer of biological materials

PLoS biology, 2018-08, Vol.16 (8), p.e2006031-e2006031

2018

Volltextzugriff (PDF)

Commercialization and Collaboration: Competing Policies in Publicly Funded Stem Cell Research?

Cell stem cell, 2010-07, Vol.7 (1), p.25-30

2010

Volltextzugriff (PDF)

Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada

Frontiers in medicine, 2019-03, Vol.6, p.58-58

2019

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

“If they tell me to get it, I'll get it. If they don't….”: Immunization decision-making processes of immigrant mothers

The global landscape of stem cell clinical trials

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications

Application of protection motivation theory to clinical trial enrolment for pediatric chronic conditions

Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation

Let’s do better: public representations of COVID-19 science

Role and reality: technology transfer at Canadian universities

Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis

Asynchronous online focus groups for research with people living with amyotrophic lateral sclerosis and family caregivers: usefulness, acceptability and lessons learned

Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis

Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness

Governance of a global genetic resource commons for non-commercial research: a case-study of the DNA barcode commons

Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers

Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

Is belief larger than fact: expectations, optimism and reality for translational stem cell research

Patent landscaping for life sciences innovation: toward consistent and transparent practices

When pictures waste a thousand words: analysis of the 2009 H1N1 pandemic on television news

"I have such a hard time hitting myself, I thought it'd be easier": perspectives of hospitalized patients on injecting drugs into vascular access devices

Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate

The Impact of Heterogeneity in a Global Knowledge Commons: Implications for Governance of the DNA Barcode Commons

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

Provenance and risk in transfer of biological materials

Commercialization and Collaboration: Competing Policies in Publicly Funded Stem Cell Research?

Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada

Suchergebnisse filtern